A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Fixed Dose Combination of Biktarvy versus Tivicay and Descovy in Treatment Naive, HIV-1 and Hepatits B CoInfected Adultsmidwayadmin2019-04-23T19:32:02+00:00
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Fixed Dose Combination of Biktarvy versus Tivicay and Descovy in Treatment Naive, HIV-1 and Hepatits B CoInfected Adults
GS-US-380-4458 · Trial ·
Major Inclusion/Exclusion Criteria
- New diagnosis of HIV and Hepatitis B and never taken medications to treat
- Can not be co-infected with Hepatitis C
- Can not have decompensated cirrhosis